Your browser doesn't support javascript.
loading
Teprotumumab-related Cutaneous Hypersensitivity Reactions.
Dallalzadeh, Liane O; Ting, Michelle; Topilow, Nicole; Robbins, Shira L; Liu, Catherine Y; Burkat, Cat N; Korn, Bobby S; Kikkawa, Don O.
Afiliação
  • Dallalzadeh LO; Division of Oculofacial Plastic and Reconstructive Surgery, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, UC San Diego, La Jolla, CA, U.S.A.
  • Ting M; Division of Oculofacial Plastic and Reconstructive Surgery, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, UC San Diego, La Jolla, CA, U.S.A.
  • Topilow N; Division of Oculofacial Plastic and Reconstructive Surgery, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, UC San Diego, La Jolla, CA, U.S.A.
  • Robbins SL; Division of Pediatric Ophthalmology and Adult Strabismus, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA, U.S.A.
  • Liu CY; Division of Oculofacial Plastic and Reconstructive Surgery, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, UC San Diego, La Jolla, CA, U.S.A.
  • Burkat CN; Division of Ophthalmic Facial Plastic Surgery, Department of Ophthalmology and Visual Sciences, University of Wisconsin Madison, Madison, WI, U.S.A.
  • Korn BS; Division of Oculofacial Plastic and Reconstructive Surgery, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, UC San Diego, La Jolla, CA, U.S.A.
  • Kikkawa DO; Division of Plastic and Reconstructive Surgery, Department of Surgery, UC San Diego, La Jolla, CA, U.S.A.
Ophthalmic Plast Reconstr Surg ; 39(6): e208-e210, 2023.
Article em En | MEDLINE | ID: mdl-37656913

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oftalmopatia de Graves / Anticorpos Monoclonais Humanizados Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oftalmopatia de Graves / Anticorpos Monoclonais Humanizados Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article